Jamieson L

What will it take for an injectable ARV to change the face of the HIV epidemic in high-prevalence countries? Considerations regarding drug costs and operations.
Meyer-Rath G, Jamieson L, Pillay Y

Journal of the International AIDS Society

(2023)

https://doi.org/10.1002/jia2.26106
The role of modelling in planning and budgeting for South Africa’s COVID-19 response
Silal SP, Pulliam JRC, Jamieson L, Nichols B, Moultrie H, Meyer-Rath G

PLOS Global Public Health

(2023)

https://doi.org/10.1371/journal.pgph.0001063
The role of modelling and analytics in South African COVID-19 planning and budgeting
Meyer-Rath G, Hounsell RA, Pulliam JRC, Jamieson L, Nichols BE, Moultrie H, Silal SP

PLoS Global Public Health

(2023)

https://doi.org/10.1371/journal.pgph.0001063
Differential in-hospital mortality and intensive care treatment over time: Informing hospital pathways for modelling COVID-19 in South Africa
Jamieson L, van Schalkwyk C, Nichols BE, Meyer-Rath G, Silal SP, Pulliam JRC, Blumberg L, Cohen C, Moultrie H, Jassat W

PLoS Global Public Health

(2023)

https://doi.org/10.1371/journal.pgph.0001073
The National COVID-19 Epi Model (NCEM): estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa
Silal SP, Pulliam JRC, Meyer-Rath G, Jamieson L, Nichols BE, Norman J, Hounsell R, Mayet S, Kagoro F, Moultrie H

PLoS Global Public Health

(2023)

https://doi.org/10.1371/journal.pgph.0001070
Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 treatment in South Africa
Youngji J, Jamieson L, Edoka I, Long L, Silal SP, Pulliam JRC, Moultrie H, Sanne I, Meyer-Rath G, Nichols BE

Open Forum Infectious Diseases

(2021)

https://doi.org/10.1093/ofid/ofab040
The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing intensive care unit capacity
Nichols BE, Jamieson L, Zhang SRC, Rao GA, Silal SP, Pulliam JRC, Sanne I, Meyer-Rath G

Clinical Infectious Diseases

(2020)

https://doi.org/10.1093/cid/ciaa937